In the last trading session, 5,883,485 shares of the Timber Pharmaceuticals, Inc.(NYSE:TMBR) were traded, and its beta was 0.52. Most recently the company’s share price was $1.88, and it changed around -$0.26 or -0.12% from the last close, which brings the market valuation of the company to $22.28 Million. TMBR currently trades at a discount to its 52-week high of $10.44, offering almost -455.32% off that amount. The share price’s 52-week low was $0.665, which indicates that the current value has risen by an impressive 64.63% since then. We note from Timber Pharmaceuticals, Inc.’s average daily trading volume that its 10-day average is 11.26 Million shares, with the 3-month average coming to 6.81 Million.
Timber Pharmaceuticals, Inc. stock received a consensus recommendation rating of Hold, based on a mean score of 3. If we narrow it down even further, the data shows that none out of 1 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, 1 recommended TMBR as a Hold, whereas none deemed it a Buy, and no one rated it as Underweight. Timber Pharmaceuticals, Inc. is expected to report earnings per share of $0 for the current quarter.
Timber Pharmaceuticals, Inc. (NYSE:TMBR): Trading Information
Although TMBR has showed a red trend with a performance of -12.15% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $3.15 on Tuesday, Feb 16 increased the stock’s daily price by 40.32%. The company’s shares are currently up 1.53% year-to-date, but still down -0.2 over the last five days. On the other hand, Timber Pharmaceuticals, Inc. (NYSE:TMBR) is 0.65% up in the 30-day period. We can see from the shorts that 1.54 Million shares have been sold at a short interest cover period of 0.23 day(s).
The consensus price target as assigned by Wall Street analysts is $12, which translates to bears needing to increase their stock price by 538.3% from its current value. Analyst projections state that TMBR is forecast to be at a low of $12 and a high of $12. In order for the stock price to hit the forecast high, the stock would need to surge +538.3% from its current level, while the stock would need to crash 538.3% from its current level to reach the projected low.
Timber Pharmaceuticals, Inc. (TMBR) projections and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 22.7%. Timber Pharmaceuticals, Inc. earnings are expected to increase by 66.4% in 2021, but the outlook is negative 0% per year for the next five years.
Timber Pharmaceuticals, Inc. (NYSE:TMBR)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 46.72% of Timber Pharmaceuticals, Inc. shares, and 12.3% of them are in the hands of institutional investors. The stock currently has a share float of 23.08%. Timber Pharmaceuticals, Inc. stock is held by 11 institutions, with Bridgeway Capital Management, Inc. being the largest institutional investor. By Dec 30, 2020, it held 1.32% of the shares, which is about 158.3 Thousand shares worth $117.62 Thousand.
Two Sigma Securities, LLC, with 0.15% or 17.58 Thousand shares worth $13.06 Thousand as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Bridgeway Funds Inc-Ultra Small Company Fund and Bridgeway Funds Inc-Ultra Small Company Market Fund were the top two Mutual Funds as of Dec 30, 2020. The former held 107800 shares worth $80.1 Thousand, making up 0.9% of all outstanding shares. On the other hand, Bridgeway Funds Inc-Ultra Small Company Market Fund held roughly 44.1 Thousand shares worth around $32.77 Thousand, which represents about 0.37% of the total shares outstanding.